Laserscope shares rise on $715m merger agreement with American Medical Systems
This article was originally published in Clinica
Laserscope this week saw its share price soar 43% to hit $30.65, the highest it has reached since November 2005, following news that it was to be acquired by urology company American Medical Systems (AMS). Minnetonka, Minnesota-based AMS definitively agreed on Monday (June 5) to purchase all outstanding shares of Laserscope at $31 per share in cash, giving the transaction a total value of around $715m.
You may also be interested in...
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.